Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 3,350,000 | 3,874,182 | +524,182 | $167.37M | $162.91M | 11.94% | -$4.46M |
| Vaxcyte, Inc.(PCVX) | 920,000 | 1,625,000 | +705,000 | $105.13M | $133.02M | 9.75% | +$27.89M |
| Nuvalent Inc | 940,000 | 1,621,600 | +681,600 | $96.16M | $126.94M | 9.30% | +$30.78M |
| Xenon Pharmaceuticals Inc.(XENE) | 2,700,000 | 2,740,000 | +40,000 | $106.30M | $107.41M | 7.87% | +$1.11M |
| Enliven Therapeutics Inc | 4,100,000 | 4,205,000 | +105,000 | $104.71M | $94.61M | 6.93% | -$10.10M |
| Vera Therapeutics, Inc.CL A(VERA) | 2,475,000 | 1,958,600 | -516,400 | $109.39M | $82.83M | 6.07% | -$26.57M |
| Soleno Therapeutics Inc | 1,260,000 | 1,525,000 | +265,000 | $63.62M | $68.55M | 5.02% | +$4.93M |
| Alkermes plcSHS(ALKS) | 2,900,000 | 2,300,000 | -600,000 | $81.17M | $66.15M | 4.85% | -$15.02M |
| Nurix Therapeutics, Inc.(NRIX) | 1,650,000 | 3,000,000 | +1,350,000 | $37.08M | $56.52M | 4.14% | +$19.44M |
| Cogent Biosciences, Inc.(COGT) | 7,539,930 | 6,881,629 | -658,301 | $81.43M | $53.68M | 3.93% | -$27.75M |
| Spyre Therapeutics, Inc.(SYRE) | 1,988,084 | 1,988,084 | 0 | $58.47M | $46.28M | 3.39% | -$12.19M |
| Viridian Therapeutics, Inc.(VRDN) | 2,550,124 | 2,400,000 | -150,124 | $58.02M | $46.01M | 3.37% | -$12.01M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 950,000 | +950,000 | $0 | $41.06M | 3.01% | +$41.06M |
| Centessa Pharmaceuticals PlcADS | 1,350,000 | 2,218,425 | +868,425 | $21.59M | $37.16M | 2.72% | +$15.57M |
| Pharvaris N V COM | 1,911,433 | 1,911,433 | 0 | $35.40M | $36.64M | 2.69% | +$1.24M |
| Mind Medicine Mindmed Inc | 8,000,000 | 4,308,425 | -3,691,575 | $45.52M | $29.99M | 2.20% | -$15.53M |
| Oruka Therapeutics, Inc.(ORKA) | 1,369,714 | 1,419,714 | +50,000 | $33.57M | $27.53M | 2.02% | -$6.04M |
| Cardiff Oncology, Inc.(CRDF) | 0 | 5,384,616 | +5,384,616 | $0 | $23.37M | 1.71% | +$23.37M |
| Inhibikase Therapeutics, Inc.(IKT) | 0 | 5,925,000 | +5,925,000 | $0 | $19.26M | 1.41% | +$19.26M |
| Neurogene Inc.(NGNE) | 200,000 | 800,000 | +600,000 | $8.39M | $18.29M | 1.34% | +$9.90M |
| Bright Minds Biosciences Inc.(DRUG) | 0 | 500,000 | +500,000 | $0 | $18.01M | 1.32% | +$18.01M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 2,000,000 | 2,000,000 | 0 | $20.50M | $16.14M | 1.18% | -$4.36M |
| Apogee Therapeutics Inc | 290,000 | 290,000 | 0 | $17.03M | $13.14M | 0.96% | -$3.90M |
| ABIVAX Société AnonymeADS(ABVX) | 1,284,110 | 1,284,110 | 0 | $14.79M | $9.40M | 0.69% | -$5.39M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.51M | $7.63M | 0.56% | +$127.5K |
| Helix Acquisition Corp IiCL A | 500,000 | 500,000 | 0 | $5.22M | $5.25M | 0.38% | +$25.1K |
| Celcuity Inc.(CELC) | 1,522,332 | 400,000 | -1,122,332 | $22.70M | $5.24M | 0.38% | -$17.46M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,575,000 | 1,575,000 | 0 | $4.74M | $4.65M | 0.34% | -$94.5K |
| Avalo Therapeutics, Inc.(AVTX) | 483,000 | 483,000 | 0 | $4.59M | $3.59M | 0.26% | -$999.8K |
| Third Harmonic Bio Inc | 1,360,569 | 237,704 | -1,122,865 | $18.44M | $2.45M | 0.18% | -$15.99M |
| Nkarta, Inc.(NKTX) | 4,662,073 | 351,848 | -4,310,225 | $21.07M | $876.1K | 0.06% | -$20.20M |
| Arvinas, Inc.(ARVN) | 1,200,000 | 0 | -1,200,000 | $29.56M | $0 | — | -$29.56M |
| C4 Therapeutics, Inc.(CCCC) | 3,410,384 | 0 | -3,410,384 | $19.44M | $0 | — | -$19.44M |
| Cabaletta Bio, Inc.(CABA) | 1,100,000 | 0 | -1,100,000 | $5.19M | $0 | — | -$5.19M |
| Celldex Therapeutics, Inc.(CLDX) | 1,618,937 | 0 | -1,618,937 | $55.03M | $0 | — | -$55.03M |
| Instil Bio, Inc.(TIL) | 150,929 | 0 | -150,929 | $10.16M | $0 | — | -$10.16M |
| Kura Oncology, Inc.(KURA) | 1,800,000 | 0 | -1,800,000 | $35.17M | $0 | — | -$35.17M |
| Perspective Therapeutics, Inc.(CATX) | 3,350,000 | 0 | -3,350,000 | $44.72M | $0 | — | -$44.72M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 650,000 | 0 | -650,000 | $34.05M | $0 | — | -$34.05M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 885,000 | 0 | -885,000 | $17.04M | $0 | — | -$17.04M |